PeopleBio, Inc. (KOSDAQ:304840)
South Korea
· Delayed Price · Currency is KRW 2,570.00
-20.00 (-0.77%)
At close: Jun 5, 2025, 3:30 PM KST
PeopleBio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -10,617 | -10,913 | -16,035 | -14,303 | -4,697 | -4,383 |
| Depreciation & Amortization | 1,705 | 1,692 | 1,565 | 1,282 | 734.08 | 284.48 |
| Loss (Gain) From Sale of Assets | - | - | - | -17.65 | -5.17 | -6.9 |
| Asset Writedown & Restructuring Costs | 63.62 | 63.62 | - | - | - | - |
| Loss (Gain) From Sale of Investments | 387.71 | 392.52 | 395.43 | - | - | - |
| Loss (Gain) on Equity Investments | 953.93 | 988.33 | 934.89 | 835.96 | 380.5 | - |
| Stock-Based Compensation | - | - | - | - | - | 325.61 |
| Provision & Write-off of Bad Debts | 44.92 | 84.73 | - | - | - | 275 |
| Other Operating Activities | -1,234 | -1,580 | 61.43 | 2,299 | -2,450 | 207.43 |
| Change in Accounts Receivable | 482.41 | 223.68 | -1,502 | -1,553 | 179.63 | -33.31 |
| Change in Inventory | -328.4 | -564.74 | -1,877 | -214 | -156.09 | -117.51 |
| Change in Accounts Payable | -16.72 | -104.56 | -156.63 | 259.4 | -157.08 | 105.98 |
| Change in Other Net Operating Assets | -1,370 | -1,194 | 331.87 | -2,563 | -661.94 | -151.57 |
| Operating Cash Flow | -9,927 | -10,911 | -16,282 | -13,975 | -6,833 | -3,494 |
| Capital Expenditures | -20.1 | -78.6 | -719.15 | -1,267 | -1,355 | -157.99 |
| Sale of Property, Plant & Equipment | - | - | - | 33.25 | 29 | 29 |
| Cash Acquisitions | - | - | - | - | 25.73 | - |
| Sale (Purchase) of Intangibles | -27.79 | -36.14 | -41.08 | -73.12 | -35.3 | -47.35 |
| Investment in Securities | -3,109 | -578.29 | 2,967 | -10,300 | -2,415 | -282.21 |
| Other Investing Activities | 9.92 | 18.83 | -890.93 | 64.94 | -217.79 | 8.65 |
| Investing Cash Flow | -3,147 | -674.2 | 1,316 | -11,542 | -3,968 | -449.9 |
| Long-Term Debt Issued | - | 14,850 | - | - | 31,000 | - |
| Long-Term Debt Repaid | - | -2,694 | -27,048 | -684.16 | -1,333 | -143.97 |
| Net Debt Issued (Repaid) | 13,745 | 12,156 | -27,048 | -684.16 | 29,667 | -143.97 |
| Issuance of Common Stock | - | - | 29,606 | 1,036 | 12,992 | 10,155 |
| Repurchase of Common Stock | - | - | -26.02 | - | - | - |
| Other Financing Activities | -0 | -0 | -518.45 | -1.75 | 691.99 | - |
| Financing Cash Flow | 13,745 | 12,156 | 2,014 | 350.08 | 43,351 | 10,011 |
| Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | - | - | - |
| Net Cash Flow | 670.21 | 570.56 | -12,952 | -25,166 | 32,550 | 6,067 |
| Free Cash Flow | -9,948 | -10,990 | -17,001 | -15,242 | -8,188 | -3,652 |
| Free Cash Flow Margin | -264.10% | -294.51% | -381.80% | -342.91% | -1418.84% | -719.10% |
| Free Cash Flow Per Share | -457.63 | -505.76 | -1025.76 | -1041.91 | -510.46 | -300.93 |
| Cash Interest Paid | 162.71 | 184.05 | 251.37 | 206.88 | 106.75 | 24.83 |
| Cash Income Tax Paid | - | -22.45 | -16.06 | 54.65 | 5.68 | -7.35 |
| Levered Free Cash Flow | -526.23 | -1,896 | -28,889 | -13,378 | 9,824 | - |
| Unlevered Free Cash Flow | 403.97 | -1,227 | -27,390 | -11,516 | 10,532 | - |
| Change in Net Working Capital | -5,518 | -4,384 | 18,664 | 4,147 | -15,711 | - |
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.